Literature DB >> 16401081

Role of Tyr348 in Tyr385 radical dynamics and cyclooxygenase inhibitor interactions in prostaglandin H synthase-2.

Corina E Rogge1, Bryant Ho, Wen Liu, Richard J Kulmacz, Ah-Lim Tsai.   

Abstract

Both prostaglandin H synthase (PGHS) isoforms utilize a radical at Tyr385 to abstract a hydrogen atom from arachidonic acid, initializing prostaglandin synthesis. A Tyr348-Tyr385 hydrogen bond appears to be conserved in both isoforms; this hydrogen bonding has the potential to modulate the positioning and reactivity of the Tyr385 side chain. The EPR signal from the Tyr385 radical undergoes a time-dependent transition from a wide doublet to a wide singlet species in both isoforms. In PGHS-2, this transition results from radical migration from Tyr385 to Tyr504. Localization of the radical to Tyr385 in the recombinant human PGHS-2 Y504F mutant was exploited in examining the effects of blocking Tyr385 hydrogen bonding by introduction of a further Y348F mutation. Cyclooxygenase and peroxidase activities were found to be maintained in the Y348F/Y504F mutant, but the Tyr385 radical was formed more slowly and had greater rotational freedom, as evidenced by observation of a transition from an initial wide doublet species to a narrow singlet species, a transition not seen in the parent Y504F mutant. The effect of disrupting Tyr385 hydrogen bonding on the cyclooxygenase active site structure was probed by examination of cyclooxygenase inhibitor kinetics. Aspirin treatment eliminated all oxygenase activity in the Y348F/Y504F double mutant, with no indication of the lipoxygenase activity observed in aspirin-treated wild-type PGHS-2. Introduction of the Y348F mutation also strengthened the time-dependent inhibitory action of nimesulide. These results suggest that removal of Tyr348-Tyr385 hydrogen bonding in PGHS-2 allows greater conformational flexibility in the cyclooxygenase active site, resulting in altered interactions with inhibitors and altered Tyr385 radical behavior.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16401081      PMCID: PMC2851202          DOI: 10.1021/bi051235w

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  42 in total

1.  Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site.

Authors:  P J Loll; D Picot; O Ekabo; R M Garavito
Journal:  Biochemistry       Date:  1996-06-11       Impact factor: 3.162

2.  Detection of an Fe2+-protoporphyrin-IX intermediate during aspirin-treated prostaglandin H2 synthase II catalysis of arachidonic acid to 15-HETE.

Authors:  M S Tang; R A Copeland; T M Penning
Journal:  Biochemistry       Date:  1997-06-17       Impact factor: 3.162

3.  Analysis of hydroperoxide-induced tyrosyl radicals and lipoxygenase activity in aspirin-treated human prostaglandin H synthase-2.

Authors:  G Xiao; A L Tsai; G Palmer; W C Boyar; P J Marshall; R J Kulmacz
Journal:  Biochemistry       Date:  1997-02-18       Impact factor: 3.162

4.  Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2.

Authors:  C Luong; A Miller; J Barnett; J Chow; C Ramesha; M F Browner
Journal:  Nat Struct Biol       Date:  1996-11

Review 5.  Prostaglandin endoperoxide H synthases-1 and -2.

Authors:  W L Smith; D L Dewitt
Journal:  Adv Immunol       Date:  1996       Impact factor: 3.543

6.  Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.

Authors:  R G Kurumbail; A M Stevens; J K Gierse; J J McDonald; R A Stegeman; J Y Pak; D Gildehaus; J M Miyashiro; T D Penning; K Seibert; P C Isakson; W C Stallings
Journal:  Nature       Date:  1996 Dec 19-26       Impact factor: 49.962

Review 7.  Prostaglandin synthase 2.

Authors:  H R Herschman
Journal:  Biochim Biophys Acta       Date:  1996-01-05

8.  Role of Val509 in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents.

Authors:  Q Guo; L H Wang; K H Ruan; R J Kulmacz
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

9.  The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase.

Authors:  P J Loll; D Picot; R M Garavito
Journal:  Nat Struct Biol       Date:  1995-08

10.  The kinetic factors that determine the affinity and selectivity for slow binding inhibition of human prostaglandin H synthase 1 and 2 by indomethacin and flurbiprofen.

Authors:  O H Callan; O Y So; D C Swinney
Journal:  J Biol Chem       Date:  1996-02-16       Impact factor: 5.157

View more
  13 in total

Review 1.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

2.  Structural comparisons of arachidonic acid-induced radicals formed by prostaglandin H synthase-1 and -2.

Authors:  Ah-lim Tsai; Gang Wu; Corina E Rogge; Jian-Ming Lü; Sheng Peng; Wilfred A van der Donk; Graham Palmer; Gary J Gerfen; Richard J Kulmacz
Journal:  J Inorg Biochem       Date:  2010-11-27       Impact factor: 4.155

3.  Polymorphic human prostaglandin H synthase-2 proteins and their interactions with cyclooxygenase substrates and inhibitors.

Authors:  W Liu; E M Poole; C M Ulrich; R J Kulmacz
Journal:  Pharmacogenomics J       Date:  2010-06-15       Impact factor: 3.550

4.  Tuning Radical Relay Residues by Proton Management Rescues Protein Electron Hopping.

Authors:  Estella F Yee; Boris Dzikovski; Brian R Crane
Journal:  J Am Chem Soc       Date:  2019-10-28       Impact factor: 15.419

5.  Asymmetric acetylation of the cyclooxygenase-2 homodimer by aspirin and its effects on the oxygenation of arachidonic, eicosapentaenoic, and docosahexaenoic acids.

Authors:  Narayan P Sharma; Liang Dong; Chong Yuan; Kathleen R Noon; William L Smith
Journal:  Mol Pharmacol       Date:  2010-03-01       Impact factor: 4.436

6.  Characterization of the peroxidase mechanism upon reaction of prostacyclin synthase with peracetic acid. Identification of a tyrosyl radical intermediate.

Authors:  Hui-Chun Yeh; Gary J Gerfen; Jinn-Shyan Wang; Ah-Lim Tsai; Lee-Ho Wang
Journal:  Biochemistry       Date:  2009-02-10       Impact factor: 3.162

7.  Fluorescence of tryptophan in designed hairpin and Trp-cage miniproteins: measurements of fluorescence yields and calculations by quantum mechanical molecular dynamics simulations.

Authors:  Andrew W McMillan; Brandon L Kier; Irene Shu; Aimee Byrne; Niels H Andersen; William W Parson
Journal:  J Phys Chem B       Date:  2013-02-04       Impact factor: 2.991

8.  Cyclooxygenase competitive inhibitors alter tyrosyl radical dynamics in prostaglandin H synthase-2.

Authors:  Gang Wu; Ah-Lim Tsai; Richard J Kulmacz
Journal:  Biochemistry       Date:  2009-12-22       Impact factor: 3.162

9.  Peroxide-induced radical formation at TYR385 and TYR504 in human PGHS-1.

Authors:  Corina E Rogge; Wen Liu; Richard J Kulmacz; Ah-Lim Tsai
Journal:  J Inorg Biochem       Date:  2009-04-17       Impact factor: 4.155

10.  A Revised Mechanism for Human Cyclooxygenase-2.

Authors:  Yi Liu; Justine P Roth
Journal:  J Biol Chem       Date:  2015-11-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.